Brigitte Boisselier
From Wikipedia, the free encyclopedia
 |
This article may require cleanup to meet Wikipedia's quality standards. Please discuss this issue on the talk page or replace this tag with a more specific message. This article has been tagged since March 2007. |
Dr. Brigitte Boisselier is the head of Clonaid, the "scientific wing" of the Raelians. She is primarily known for claiming that the company, run by the church, was the first organization to clone a full human being in the early 2000s. However, this claim was never backed up by any kind of evidence and was generally believed, as it is today, that it was purely a publicity stunt.
On December 27, 2002, Dr. Brigitte Boisselier, a Raëlian bishop and CEO of Clonaid, announced to the world press that Clonaid had successfully cloned a human being. Boisselier said that the mother delivered by Caesarean section somewhere outside the United States, and that both the mother and the little girl, Eve, are healthy. Dr. Boisselier did not present the mother or child, or any DNA samples that could be used to confirm her claim at the press conference, although she did explain the procedure which she intended to use to confirm her claims. It has subsequently become apparent that the announcement was made prior to genetic testing to evaluate whether the child in question is actually a clone: Dr. Boisselier was therefore stating her belief that her procedure had resulted in a clone, not announcing results showing that the child was a clone.
On January 2, 2003, Dr. Boisselier told a French television audience that the American parents of the supposed clone are balking at providing DNA evidence to prove that their baby is really a clone. The parents are allegedly afraid that the state of Florida will try to take the baby away from them.
On January 4, 2003, Boisselier announced the birth of another cloned baby to a Dutch lesbian couple. Clonaid also said there would be four other cloned babies delivered by February 2003.
She holds a master's degree in biochemistry and a doctorate in physical chemistry from the University of Dijon in France and another Phd in analytical chemistry from the University of Houston in the United States under the guidance of Prof. Karl Kadish.
